Philippe Hernigou
University of Paris-Est
5 Papers
2 Citations
Philippe Hernigou is an academic researcher from University of Paris-Est. The author has contributed to research in topics: Evidence-based practice & Retrospective cohort study. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Bone Marrow Concentrate (BMC) Therapy in Musculoskeletal Disorders: Evidence-Based Policy Position Statement of American Society of Interventional Pain Physicians (ASIPP).
Laxmaiah Manchikanti,Laxmaiah Manchikanti,Christopher J. Centeno,Sairam Atluri,Sheri L. Albers,Shane A. Shapiro,Gerard A. Malanga,Alaa Abd-Elsayed,Mairin A Jerome,Joshua A Hirsch,Alan D. Kaye,Alan D. Kaye,Alan D. Kaye,Steve M. Aydin,Douglas P. Beall,Don Buford,Joanne Borg-Stein,Ricardo M. Buenaventura,Joseph A Cabaret,Aaron K. Calodney,Kenneth D. Candido,Cameron Cartier,Richard E. Latchaw,Sudhir Diwan,Ehren Dodson,Zachary Fausel,Michael Fredericson,Christopher Gharibo,Mayank Gupta,Adam M. Kaye,Nebojsa Nick Knezevic,Radomir Kosanovic,Matthew Lucas,Maanasa V Manchikanti,R Amadeus Mason,Kenneth Mautner,Samuel Murala,Annu Navani,Vidyasagar Pampati,Sarah M. Pastoriza,Ramarao Pasupuleti,Cyril Philip,Mahendra R Sanapati,Theodore Sand,Rinoo V. Shah,Amol Soin,Ian Stemper,Bradley W. Wargo,Philippe Hernigou +48 more
TL;DR: The current regulatory guidelines set in place by the FDA are described, specifically the terminology around "minimal manipulation" and "homologous use" within Regulation 21 CFR Part 1271, and specifically how this applies to the use of BMC in interventional musculoskeletal medicine are described.
What every surgeon should know about Ceramic-on-Ceramic bearings in young patients
Philippe Hernigou,François Roubineau,Charlie Bouthors,Charles-Henri Flouzat-Lachaniette +3 more
- 01 Apr 2016
TL;DR: It is recommended that surgeons weigh the potential advantages and disadvantages of current CoC THA in comparison with other bearing surfaces when considering young very active patients who are candidates for THA.
27
•Journal Article
Knee Osteonecrosis: Cell Therapy with Computer-assisted Navigation.
TL;DR: Computer navigation may be safely used in a basic procedure for the injection of stem cells in knee osteonecrosis, with results closer to the ideal position of the trocar, with better trocar placement in terms of tip-to-subchondral distance and ideal center position within the target for injection ofstem cells.
10
•Journal Article
Targeting Core Decompression and Cell Therapy Injection of Hip Osteonecrosis with Computer-Assisted Navigation
TL;DR: The findings suggest that computer-assisted navigation may be safely used to train surgical novices in core decompression and might improve precision with less radiation, which might be desirable in cell therapy.
2
Staying home during "COVID-19" decreased fractures, but trauma did not quarantine in one hundred and twelve adults and twenty eight children and the "tsunami of recommendations" could not lockdown twelve elective operations.
TL;DR: The structural organization in the hospital allowed an integrated team of orthopaedic surgeons to reduce the time to surgery and ultimately hospital stay, thereby maximizing the already stretched medical resources available to treat all the patients who needed orthopedic care during this period.